Arca
Skip to content

BioWave BioWraps

Electrode, Cutaneous. 510(k) K261522, from Biowave Corporation (Westport, CT). Product code GXY, class 2.

As of Nov 17, 2026, K261522 is an FDA 510(k) held by Biowave Corporation, substantially equivalent on Jun 3, 2026 after 27 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 3, 2026
  • Review time: 27 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The BioWave BioWraps are cutaneous electrodes to be used with legally marketed BioWave branded neurostimulators. The knitted garment electrodes are non -sterile reusable prescription -use conductive garments that are intended to deliver the stimulation signals generated by the stimulator to the body surface with which they are in contact.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other GXY Clearances

The newest 510(k)s for the same product code; their median review was 144 days; see every GXY device

Record

Type
Special
Received
May 7, 2026
Review panel
Neurology
Regulation
21 CFR 882.1320

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.